ADMA Biologics (ADMA) News Today $20.22 -0.10 (-0.49%) Closing price 04:00 PM EasternExtended Trading$20.39 +0.17 (+0.82%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Advantage Alpha Capital Partners LP Sells 18,209 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Advantage Alpha Capital Partners LP lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 20.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 69,182 shares of the biotechnology company's stock after selling 18,209 shares during the perioMarch 25 at 6:07 AM | marketbeat.comCibc World Markets Corp Acquires Shares of 21,076 ADMA Biologics, Inc. (NASDAQ:ADMA)Cibc World Markets Corp bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 21,076 shares of the biotechnology companyMarch 25 at 3:53 AM | marketbeat.comSimplify Asset Management Inc. Acquires Shares of 385,188 ADMA Biologics, Inc. (NASDAQ:ADMA)Simplify Asset Management Inc. bought a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 385,188 shares of the biotechnology company's stock, valuedMarch 24 at 6:18 AM | marketbeat.comSummit Global Investments Buys New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)Summit Global Investments bought a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 45,425 shares of the biotechnology cMarch 24 at 4:49 AM | marketbeat.comHillsdale Investment Management Inc. Decreases Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Hillsdale Investment Management Inc. trimmed its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 4.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 323,700 shares of the biotechnologyMarch 23 at 6:43 AM | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Purchased by Swiss National BankSwiss National Bank raised its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 6.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 458,400 shares of the biotechnology company's stock afterMarch 23 at 3:35 AM | marketbeat.comFY2025 EPS Estimates for ADMA Biologics Raised by AnalystADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) - Research analysts at Cantor Fitzgerald upped their FY2025 earnings per share estimates for ADMA Biologics in a research note issued on Thursday, March 20th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will eMarch 22 at 7:20 AM | marketbeat.comIntech Investment Management LLC Purchases 48,636 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Intech Investment Management LLC grew its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 78.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 110,756 shares of the biotechnology company's stMarch 22 at 4:45 AM | marketbeat.comFY2025 EPS Forecast for ADMA Biologics Increased by AnalystMarch 22 at 2:17 AM | americanbankingnews.comADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future PotentialMarch 21, 2025 | seekingalpha.comADMA Biologics (NASDAQ:ADMA) Trading Up 6.1% - Time to Buy?ADMA Biologics (NASDAQ:ADMA) Stock Price Up 6.1% - Here's WhyMarch 20, 2025 | marketbeat.comStock Market Jumps After Powell Commentary; Breakouts Still Sparse, But LandBridge Passes MusterMarch 20, 2025 | msn.comWhy ADMA Biologics Inc. (ADMA) Went Up On Wednesday?March 20, 2025 | msn.comRoyce & Associates LP Purchases Shares of 420,569 ADMA Biologics, Inc. (NASDAQ:ADMA)Royce & Associates LP purchased a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 420,569 shares of the biotechnology company's stock, valued at approximately $7,213,00March 19, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $2.81 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Connor Clark & Lunn Investment Management Ltd. decreased its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 72.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 163,886 shares ofMarch 18, 2025 | marketbeat.comVictory Capital Management Inc. Buys 38,002 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Victory Capital Management Inc. increased its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 52.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 109,948 shares of the biotechnology company's sMarch 18, 2025 | marketbeat.comRaymond James Financial Inc. Invests $19.08 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Raymond James Financial Inc. acquired a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 1,112,275 shares of the biotechnology company's stock, valued at approMarch 17, 2025 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. boosted its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,440,294 shares of the biotechnoloMarch 16, 2025 | marketbeat.comCommit To Buy ADMA Biologics At $10, Earn 14% Using OptionsMarch 12, 2025 | nasdaq.comAdma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving AverageMarch 12, 2025 | msn.comBank of New York Mellon Corp Has $26.09 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Bank of New York Mellon Corp grew its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 10.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,521,166 shares of the biotechnology company's stMarch 10, 2025 | marketbeat.comInceptionr LLC Purchases Shares of 26,378 ADMA Biologics, Inc. (NASDAQ:ADMA)Inceptionr LLC purchased a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 26,378 shares of the biotechnology company's stock, valued at approximaMarch 9, 2025 | marketbeat.comLisanti Capital Growth LLC Sells 59,565 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Lisanti Capital Growth LLC cut its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 25.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 175,470 shares of the biotechnology company's stocMarch 8, 2025 | marketbeat.comHow This Top Small-Cap Growth Fund Wins BigMarch 7, 2025 | investors.comOppenheimer & Co. Inc. Trims Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Oppenheimer & Co. Inc. trimmed its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 59.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,416 shares of the biotechnology company's stoMarch 7, 2025 | marketbeat.com20,000 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Acquired by First Business Financial Services Inc.First Business Financial Services Inc. bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 20,000 shares of the biotechnology company'sMarch 6, 2025 | marketbeat.comEarnings call transcript: ADMA Biologics Q4 2024 beats EPS forecastMarch 5, 2025 | investing.comADMA Biologics (NASDAQ:ADMA) Shares Gap Down - Should You Sell?ADMA Biologics (NASDAQ:ADMA) Shares Gap Down - Here's What HappenedMarch 5, 2025 | marketbeat.comADMA Biologics slips as 10-K delay overshadows earnings beatMarch 4, 2025 | msn.comBREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of ControlsMarch 4, 2025 | globenewswire.comADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | insidermonkey.comADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | msn.comADMA Biologics' (ADMA) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and issued a $25.00 price target on shares of ADMA Biologics in a research note on Tuesday.March 4, 2025 | marketbeat.comAdma Biologics options imply 11.5% move in share price post-earningsMarch 4, 2025 | markets.businessinsider.comAdma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year OutlookMarch 4, 2025 | msn.comADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | seekingalpha.comADMA Biologics (NASDAQ:ADMA) Announces Earnings ResultsADMA Biologics (NASDAQ:ADMA - Get Free Report) released its quarterly earnings results on Monday. The biotechnology company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). ADMA Biologics had a net margin of 17.80% and a return on equity of 53.20%.March 3, 2025 | marketbeat.comADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 3, 2025 | globenewswire.comY Intercept Hong Kong Ltd Takes Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Y Intercept Hong Kong Ltd acquired a new position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 29,749 shares of the biotechnology company'sMarch 2, 2025 | marketbeat.comIllinois Municipal Retirement Fund Takes Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Illinois Municipal Retirement Fund acquired a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 127,160 shares of the biotechnoMarch 1, 2025 | marketbeat.comLos Angeles Capital Management LLC Has $1.43 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)Los Angeles Capital Management LLC trimmed its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 43.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 83,240 shares of the biotechnologyMarch 1, 2025 | marketbeat.comADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceFebruary 28, 2025 | globenewswire.comHandelsbanken Fonder AB Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA)Handelsbanken Fonder AB purchased a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 65,700 shares of the biotechnology company's stock, valued at apFebruary 28, 2025 | marketbeat.comIeq Capital LLC Acquires New Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Ieq Capital LLC bought a new position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 20,502 shares of the biotechnology company's stock, valued at approximately $352,000. A numbeFebruary 28, 2025 | marketbeat.comADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025February 25, 2025 | globenewswire.comPrincipal Financial Group Inc. Grows Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Principal Financial Group Inc. increased its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 5.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,259,014 shares of the biotechnology company'February 24, 2025 | marketbeat.comNavellier & Associates Inc. Acquires New Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Navellier & Associates Inc. acquired a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 178,745 shares of the biotechnology company's stock, valued aFebruary 23, 2025 | marketbeat.comNew York State Teachers Retirement System Purchases 21,976 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)New York State Teachers Retirement System lifted its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 24.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 113,090 shares of the biotechnology company's stock after acquiringFebruary 23, 2025 | marketbeat.comAdma Biologics (ADMA) Stock Moves -1.49%: What You Should KnowFebruary 21, 2025 | msn.com33,000 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Kornitzer Capital Management Inc. KSKornitzer Capital Management Inc. KS acquired a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 33,000 shares of the biotechnolFebruary 20, 2025 | marketbeat.com Remove Ads Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address ADMA Media Mentions By Week ADMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMA News Sentiment▼1.170.68▲Average Medical News Sentiment ADMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMA Articles This Week▼187▲ADMA Articles Average Week Remove Ads Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News SMMT News ITCI News MRNA News GMAB News RDY News VTRS News ASND News PCVX News QGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMA) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADMA Stock Free ADMA Stock Alerts